Skip to content

To study the effect of virechan karma and vasadi dashang kwath in the management of amlapitta

Randomized controlled clinical study of add on effect of Virechan karma and Vasadi Dashang kwath in the management of Amlapitta with special reference to Hyperacidity - Interventional

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087371
Enrollment
40
Registered
2025-05-22
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K20-K31- Diseases of esophagus, stomach and duodenum Health Condition 2: K21- Gastro-esophageal reflux disease Health Condition 3: K219- Gastro-esophageal reflux disease without esophagitis

Interventions

None listed

Sponsors

LRP Ayurvedic Hospital and Research Centre
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patient will be selected irrespective of gender,occupation and habitat 2.Those who are fit for Virechan Karma 3.Patients presenting with classic sign and symptoms of Amlapitta 4.Patient having history of hyperacidity less than 2 yrs

Exclusion criteria

Exclusion criteria: 1.Those who are not fit for Virechan karma 2.Patient having history of hyperacidity due to secondary underline cause like oesophageal carcinoma 3.Patient with cardiac problems and any other fatal disease 4.Chronic alcoholic and smoker

Design outcomes

Primary

MeasureTime frame
To study the effect of Virechan Karma and Vasadi Dashang kwath in the management of amlapittaTimepoint: 48 days

Secondary

MeasureTime frame
To Reduce the Amlapitta in 48 days To study the literature related to concept of Amlapitta To study the concept of Virechan Karma To study the concept of vasadi dashang kwathTimepoint: 48 days

Countries

India

Contacts

Public ContactDr Vinay Dadasaheb Chavan

LRP Ayurvedic Medical College and Hospital

purvachavan007@gmail.com9767676779

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026